In 2022, the European Peripheral Vascular Devices Market was valued at around €1.5 billion, and it is projected to grow at a CAGR of 3.1% during the forecast period. As a result, it is anticipated to reach approximately €1.8 billion. Throughout this medical device market research, we analyzed over 50 companies within the peripheral vascular

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

Inferior vena cava filters (IVCFs) prevent pulmonary embolism by intercepting a thrombus before it can enter the circulatory system of the lungs. In general, IVCFs are composed of a nest or lattice of wire collapsed around a catheter that is used to guide the filter. The filter is then expanded or deployed at the desired location, usually just below the junction of the inferior vena cava and the lowest renal vein.

Pulmonary embolism is a condition that affects over one million individuals each year in Europe and leads to mortality in almost a third of those afflicted. This condition is caused by the accumulation of dislodged bodies in the lungs. These usually originate from blood clots or thrombi from a deep vein in the leg.